J&J to buy cancer drug technology developer Firefly Bio for $1 billion
Original source: https://www.investing.com/news/stock-market-news/johnson–johnson-to-buy-firefly-bio-for-1-billion-4730632
Read More »J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study
Original source: https://www.investing.com/news/stock-market-news/jj-prostate-cancer-drug-reduces-risk-of-cancer-spread-and-death-in-latestage-study-4717890
Read More »GSK sees blockbuster potential in targeted cancer therapy after promising early data
Original source: https://www.investing.com/news/stock-market-news/gsk-sees-blockbuster-potential-in-targeted-cancer-therapy-after-promising-early-data-4609094
Read More »Prelude Therapeutics stock surges after FDA clears IND for cancer drug
Original source: https://www.investing.com/news/stock-market-news/prelude-therapeutics-stock-surges-after-fda-clears-ind-for-cancer-drug-93CH-4482482
Read More »Daiichi Sankyo to invest $1.9 billion in global cancer drug facilities – Nikkei
Original source: https://www.investing.com/news/stock-market-news/daiichi-sankyo-to-invest-19-billion-in-global-cancer-drug-facilities–nikkei-93CH-4428130
Read More »Greenwich LifeSciences stock soars after promising cancer trial results
Original source: https://www.investing.com/news/stock-market-news/greenwich-lifesciences-stock-soars-after-promising-cancer-trial-results-93CH-4407911
Read More »Anixa Biosciences stock rises after securing Chinese patent for cancer vaccine
Original source: https://www.investing.com/news/stock-market-news/anixa-biosciences-stock-rises-after-securing-chinese-patent-for-cancer-vaccine-93CH-4297360
Read More »GRAIL stock jumps after Samsung partnership to bring cancer test to Asia
Original source: https://www.investing.com/news/stock-market-news/grail-stock-jumps-after-samsung-partnership-to-bring-cancer-test-to-asia-93CH-4292219
Read More »Pfizer in deal with China’s 3SBio to license cancer drug candidate, take equity stake
Original source: https://www.investing.com/news/stock-market-news/pfizer-signs-up-to-6-billion-licensing-deal-with-chinas-3sbio-for-cancer-drug-4053872
Read More »Roche considering divesting $1.9 billion cancer data startup, FT reports
Original source: https://www.investing.com/news/stock-market-news/roche-considering-divesting-19-billion-cancer-data-startup-ft-reports-3558321
Read More »